Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 447

2.

Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.

Williamson MP, McCormick TG, Nance CL, Shearer WT.

J Allergy Clin Immunol. 2006 Dec;118(6):1369-74. Epub 2006 Oct 13.

PMID:
17157668
3.

Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding.

Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakage M, Hori N, Watanabe T, Takahashi K, Nagawa H.

J Allergy Clin Immunol. 2003 Nov;112(5):951-7.

PMID:
14610487
4.

Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).

Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T.

Antiviral Res. 2002 Jan;53(1):19-34.

PMID:
11684313
5.

Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry.

Gowthaman U, Jayakanthan M, Sundar D.

BMC Bioinformatics. 2008 Dec 12;9 Suppl 12:S14. doi: 10.1186/1471-2105-9-S12-S14.

6.

Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK.

Virology. 2005 Sep 1;339(2):213-25.

8.

Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.

Liu S, Lu H, Zhao Q, He Y, Niu J, Debnath AK, Wu S, Jiang S.

Biochim Biophys Acta. 2005 May 25;1723(1-3):270-81. Epub 2005 Mar 24. Erratum in: Biochim Biophys Acta. 2007 Feb;1770(2):312.

PMID:
15823507
9.

Research on anti-HIV-1 agents. Investigation on the CD4-Suradista binding mode through docking experiments.

Manetti F, Corelli F, Mongelli N, Borgia AL, Botta M.

J Comput Aided Mol Des. 2000 May;14(4):355-68.

PMID:
10815772
10.

Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.

Vermeire K, Schols D.

Expert Opin Investig Drugs. 2005 Oct;14(10):1199-212. Review.

PMID:
16185162
12.

Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1.

Lai W, Huang L, Ho P, Li Z, Montefiori D, Chen CH.

Antimicrob Agents Chemother. 2008 Jan;52(1):128-36. Epub 2007 Oct 22.

13.
14.

Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.

Teixeira C, Serradji N, Maurel F, Barbault F.

Eur J Med Chem. 2009 Sep;44(9):3524-32. doi: 10.1016/j.ejmech.2009.03.028. Epub 2009 Mar 28.

PMID:
19410340
16.

Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.

Courter JR, Madani N, Sodroski J, Schön A, Freire E, Kwong PD, Hendrickson WA, Chaiken IM, LaLonde JM, Smith AB 3rd.

Acc Chem Res. 2014 Apr 15;47(4):1228-37. doi: 10.1021/ar4002735. Epub 2014 Feb 6. Review.

17.

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.

Kwong PD, Wyatt R, Majeed S, Robinson J, Sweet RW, Sodroski J, Hendrickson WA.

Structure. 2000 Dec 15;8(12):1329-39. Erratum in: Structure Fold Des 2001 Feb 7;9(2):following R32.

PMID:
11188697
18.

A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.

Neffe AT, Meyer B.

Angew Chem Int Ed Engl. 2004 May 24;43(22):2937-40. No abstract available.

PMID:
15170309
19.

A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.

Caporuscio F, Tafi A, González E, Manetti F, Esté JA, Botta M.

Bioorg Med Chem Lett. 2009 Nov 1;19(21):6087-91. doi: 10.1016/j.bmcl.2009.09.029. Epub 2009 Sep 13.

PMID:
19783140
20.

A combination of molecular dynamics and docking calculations to explore the binding mode of ADS-J1, a polyanionic compound endowed with anti-HIV-1 activity.

Manetti F, Tintori C, Armand-Ugón M, Clotet-Codina I, Massa S, Ragno R, Esté JA, Botta M.

J Chem Inf Model. 2006 May-Jun;46(3):1344-51.

PMID:
16711753
Items per page

Supplemental Content

Write to the Help Desk